News Column

WEST PHARMACEUTICAL SERVICES INC FILES (8-K) Disclosing Regulation FD Disclosure, Financial Statements and Exhibits

July 17, 2014

Item 7.01 Regulation FD Disclosure.

On July 16, 2014, the Company issued a press release announcing the approval of a fourth-quarter dividend of $0.11 per share, a 10% increase over the $0.10 per share declared for each of the four preceding quarters. The dividend will be paid on November 5, 2014 to shareholders of record as of October 22, 2014. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (Exchange Act) or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits West Pharmaceutical Services, Inc. Press Release, dated July Exhibit 99.1 16, 2014.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters